Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905617 · ClinicalTrials.gov registry record
Post Market Clinical Experience Study of Sientra 207 Breast Implants
A clinical trial, sponsored by Tiger Biosciences.
- Terminated
- Registry status
- 113
- Enrollment target
NCT02905617: Clinical Trial study, sponsored by Tiger Biosciences.
NCT02905617 is a clinical trial that was terminated before completion, run by Tiger Biosciences. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905617 was terminated before completion, sponsored by Tiger Biosciences.
- TERMINATED
- Registry status
- 113 participants
- Enrollment target
Study Summary
A 12-month study to evaluate the clinical experience with Sientra 207 Silicone Gel Breast Implants
Primary Outcome
The primary outcome measure of the study is to obtain the Investigator Overall Satisfaction with the device using a 5-point scale where 1=definitely dissatisfied with the device to 5=definitely satisfied with the device.
Interventions
- DEVICE Sientra 207 Silicone Gel Breast Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-07-15 |
Why NCT02905617 stopped before completion
NCT02905617 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sientra 207 Silicone Gel Breast Implant is the first listed.
NCT02905617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02905617 about?
NCT02905617 is a clinical study titled "Post Market Clinical Experience Study of Sientra 207 Breast Implants". A 12-month study to evaluate the clinical experience with Sientra 207 Silicone Gel Breast Implants
What is the current status of trial NCT02905617?
This trial is currently terminated. The enrollment target is 113 participants. The study started on 2016-08. Estimated completion is 2020-07-15.
What interventions are being tested in trial NCT02905617?
The interventions under investigation include: Sientra 207 Silicone Gel Breast Implant (DEVICE).
Who is sponsoring clinical trial NCT02905617?
This trial is sponsored by Tiger Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia